2023-508759-38-00招募中1 期
A Study to Learn More About an Investigational Medicine called HDP-102 in Patients with Relapsed/Refractory B-cell Blood Cancers.
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 28
- 试验地点
- 8
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Development
Scientific
Heidelberg Pharma AG
研究点 (8)
Loading locations...
相似试验
已完成
1 期
A Study to Learn About if the Study Medicine Called Ibuzatrelvir changes how the body process the other Medicine Dabigatran Etexilate in healthy adults2024-517797-14-00Pfizer Inc.20
已完成
1 期
A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin2023-509339-17-00Pfizer Inc.6
已完成
1 期
An open-label, healthy subject, two-part study to assess the effect of verapamil on systemic exposure of EP395 (Part A), and to assess the effect of EP395 on systemic exposure of midazolam and digoxin (Part B)2023-506345-34-00Epiendo Pharmaceuticals ehf., Epiendo Pharmaceuticals ehf.36
已完成
1 期
A clinical trial in healthy people to look at how the body processes RO7268489 over time and when taken before or after a meal2023-503528-25-00F. Hoffmann-La Roche AG, F. Hoffmann-La Roche AG36
已完成
3 期
MEDLEY studyjRCT2080224799MedImmune, LLC1,500